Ambrisentan for Treatment of Portopulmonary Hypertension (NCT01733095) | Clinical Trial Compass
WithdrawnPhase 1/2
Ambrisentan for Treatment of Portopulmonary Hypertension
Stopped: slow recruitment
Austria0Started 2012-07
Plain-language summary
Portopulmonary hypertension denotes pulmonary hypertension complicating portal hypertension and is present in approximately 5% of cirrhotic patients. Treatment options include prostanoids, sildenafil, and the endothelin-receptor antagonists, bosentan and ambrisentan.
This study investigates the safety and efficacy of ambrisentan in portopulmonary hypertension.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adult patients with portal hypertension, age \>18 years
* Cirrhosis of any etiology; Child-Pugh class A and B
* Noncirrhotic portal hypertension (e.g. chronic portal vein thrombosis)
* Informed consent
Exclusion Criteria:
* Presence of other causes for pulmonary arterial hypertension
* History of pulmonary embolism or myocardial infarction within 6 months before study start
* Child-Pugh class C
* Presence of hepatocellular carcinoma
* Liver transplantation
* HIV infection
* Severe obstructive or restrictive pulmonary disease (predicted FEV1 or VC \<65%, respectively)
* Severe dilated cardiomyopathy (EF \<50%)
* Latent left-heart insufficiency
* Pregnancy and lactation
* Esophageal variceal hemorrhage within the last 6 months
* Refractory ascites
* Hepatorenal syndrome
* Persistent hepatic encephalopathy \> grade 1
* Bilirubin \>3.0 mg/dl
* AST and/or ALT \>3x ULN
* Creatinine \>2.0 mg/dl
* Known hypersensitivity to ambrisentan
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.